Check your name in voters' list online!

Bengaluru, Mar 12: Karnataka government on Wednesday issued a temporary regulation -- Karnataka Epidemic Diseases, COVID-19 Regulations, 2020 -- which aims to prevent the spread of the disease.

According to the regulation, all government and private hospitals should have flu corners for the screening of suspected cases of COVID-19.

All hospitals during the screening of such cases shall record the history of travel of the person if he or she has travelled to any country or area where COVID-19 has been reported in addition to the history of coming in contact with a suspected or confirmed case of COVID-19 shall be recorded.

Any person with a history of travel in the last 14 days to a country or area from where COVID-19 has been reported must report to the nearest government hospital or call at toll-free helpline number 104 so that necessary measures if required, may be initiated by the Department of Health and Family Welfare.

If a suspected case of COVID-19 refuses admission or isolation, the offices authorised under Section 3 of the regulation shall have powers to forcefully admit and isolate such case of a period of 14 days from the onset of symptoms or till the reports of lab tests are received, or such period as may be necessary.

No person, institution or organisation shall use print or electronic media to spread misinformation on COVID19. If a person is found indulging in any such activity, they will be punished.

If the cases of COVID-19 are reported from a defined geographic area, the district administration of the concerned district shall have the right to implement the following containment measures but not limited to these in order to prevent the spread of diseases:

* Sealing of geographic

* Barring of entry and exit of the population from the containment area

* Closure of schools, offices and banning public gathering

* Banning vehicular movement in the area

* Designating any government or private building as a containment unit for the isolation of cases

* The staff of all govt departments shall be at the disposal of the concerned district administration of the concerned area for discharging the duty of containment measures

Any person, institution or organisation found violating any of these regulations, shall be deemed to have committed an offence punishable under section 188 of the Indian Penal Code (IPC).

Bengaluru, Mar 24: Karnataka Chief Minister B S Yediyurappa, who had earlier announced that Indira canteen will supply free meals to the poor and BPL card holders, on Tuesday announced that Indira Canteens will be remain closed as there is fear of spread of the coronavirus as people assemble in large number.

On Monday, he had announced that Indira Canteens would provide food free of cost for the benefit of daily wage workers and poor people in the wake of a complete lockdown.

Asked about the alternative the government would provide, he said, "Closure of canteens is needed to avoid the rush near the canteen as it may lead to problems.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.